Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Roku, Inc. $100 Million At-The-Market Offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Roku, Inc. of its Class A common stock…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Davis Polk Advises Texas Instruments on Its $750 Million Notes Offering
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal…
Fantasia Holdings Group Co., Limited CNY1 Billion High-Yield Notes Offering
Davis Polk advised the initial purchasers in connection with a CNY1 billion Regulation S offering by Fantasia Holdings Group…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Bandwidth Inc. Follow-On Offering
Davis Polk advised the representatives of the several underwriters in connection with Bandwidth Inc.’s follow-on offering of…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…